CAAS Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,000
| Closed | -$523K | – | 469 |
|
|
2022
Q4 | $523K | Buy |
+15,000
| New | +$523K | 0.03% | 146 |
|
|
2021
Q3 | – | Sell |
-35,000
| Closed | -$5.67M | – | 738 |
|
|
2021
Q2 | $5.67M | Buy |
+35,000
| New | +$5.67M | 0.1% | 77 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 923 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 561 |
|